Related Experiment Video
Updated: Jul 20, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
[DICER1-mutant primary intracranial sarcoma: analysis of five cases]
DICER1-mutant primary intracranial sarcoma, a new tumor entity, typically presents as high-grade spindle cells in young patients. Diagnosis relies on genetic alterations in DICER1 and specific morphological features.
Area of Science:
- Neuropathology
- Oncology
- Molecular Genetics
Background:
- DICER1-mutant primary intracranial sarcoma is a recently defined tumor entity.
- It is characterized by specific genetic alterations and morphological features.
Purpose of the Study:
- To investigate the clinicopathological characteristics of DICER1-mutant primary intracranial sarcoma.
- To explore its differential diagnosis and diagnostic markers.
Main Methods:
- Retrospective analysis of five cases with clinical, imaging, and histopathological data.
- Immunohistochemistry and next-generation sequencing for genetic analysis.
- Literature review for comprehensive understanding.
Main Results:
- All five tumors were supratentorial, high-grade spindle cell sarcomas with eosinophilic globules and myogenic differentiation markers.
- Genetic analysis revealed biallelic DICER1 abnormalities in all cases, with concurrent TP53 and ATRX alterations.
- Immunophenotypically, tumors showed neuronal differentiation markers.
Conclusions:
- DICER1-mutant primary intracranial sarcoma is a distinct entity occurring in young individuals.
- Morphological features like eosinophilic globules and myogenic differentiation aid diagnosis.
- Genetic testing for DICER1 alterations is crucial for definitive diagnosis.
More Related Videos
10:31The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019